" The question is, are there useful things that we can do with the results of a genome sequence that would bring benefit? And the answer is, today, should the majority of people go and have their genome sequenced? Probably not. But are there particular circumstances in which genome sequencing is really helpful? Yes, there are. "
- Mark Walport

In today's rapidly advancing world of genetics, the benefits and implications of having one’s genome sequenced are a topic of intense discussion. Mark Walport suggests that while there might be specific scenarios where genetic sequencing can provide valuable insights and benefits, it may not be universally necessary for everyone to undergo such procedures at this time.

Walport’s statement delves into the nuanced relationship between technological advancement and practical application in medical contexts. He implies that genetic sequencing is a powerful tool but also acknowledges its limitations and potential risks. While personalized medicine holds promise for treating certain diseases more effectively, it is important to consider whether everyone would gain significant benefits from knowing their complete genetic information. This balanced view encourages further research into targeted applications where genome sequencing can indeed make a substantial difference in diagnosing or managing specific health conditions.

Mark Walport is the former Chief Scientific Adviser to the UK government and currently serves as the Chair of the Council for Science and Technology, among other prestigious roles. With his extensive background in science policy and genetic research, Walport brings valuable expertise to discussions about the ethical, social, and economic implications of advances in genetics.